HakimP.M., FearonDt, LazarusM.J.. Biocompatibility of dialysis membranes: effects of chronic complement activation.Kidney Int1984; 26: 194–200.
2.
CheungA.K., ParkerC.J., WilcoxL., JanatovaJ.. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes.Kidney Int1989; 36: 257–65.
3.
PereiraB.J.G., DinarelloC.A.. Role of cytokines in patients on hemodialysis.Int J Artif Organs1995; 18: 293–304.
4.
ChatenoudL., DugasB., BeaurainG.. Presence of preactivated T cells in hemodialyzed patients: Their possible role in altered immunity.Proc Natl Acad Sci USA1986; 83: 7457–61.
5.
ArnaoutM.A., HakimR.M., ToddR.F.III, DanaN., ColtenH.R.. Increased expression of an adhesion promoting surface glucoprotein in the granulocytopenia of hemodialysis.N Engl J Med1985; 312: 457–62.
6.
ThylenP., LundahlJ., FernvikE., HedJ., SvansonS.B., JacobsonS.H.. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis.Am J Nephrol1992; 12: 393–400.
7.
HorlW.H., ShaeferR.M., HeidlandA.. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.Am J Nephrol1985; 5: 320–26.
8.
HimmelfarbJ., LazarusM., hakimR.. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis.Am J Kidney Dis1991; 17: 271-6.
9.
AgroyannisB., DalamangasA., TzanatosH.. ALterarions in erythrocyte transformation and erythrocyte sedimentation rate during hemodialysis.Artif Organs1997; 21: 327–30.
10.
De SanctisL.B., StefoniC., CiancioloG.. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation.Int J Artif Organs1996; 19: 404–10.
11.
BommerJ., SeelingP., SeelingR., GeelingsW., BommerG., RitzE.. Determinats of palsma ß2-m concentration: possible reaction to membrane biocompatibility.Nephrol Dial Transplant1987; 2: 22–5.
12.
GeyoF., HommaN., SuzukiY., ArakawaM.. Serum level of ß2-M a new form of amyloid protein in patients undergoing long-term hemodialysis.New Engl J Med1986; 314: 585–6.
13.
De BroeM., NouwenJ., WaeleghemJ.P.. On the mechanism and site of production of ß2 microglobulin during hemodialysis.Nephrol Dial Transplant1987; 2: 124–6.
14.
KinK., KasaharaT., ItohY., SakuralayashiI., KawaiT., MoritaM.. ß2-microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated by various mitogens.Immunology1979; 36: 47–54.
15.
GoldmanM., DhaeneM., VanherweghemJ.L.. Removal of ß2-microglobulin by adsorption on dialysis membranes.Nephrol Dial Transplant1987; 2: 576–7.
16.
ZingraftJ., BeyneP., UrenaP.. Influence of hemodialysis membranes on ß2-microglobulin kinetics: In vivo and in vitro studies.Nephrol Dial Transplant1988; 3: 284–90.
17.
KostićS., DjordjevićV., LečićN., StefanovićV.. Serum ß2-microglobulin in patients on maintenance hemodialysis. The effect of dialysis membrane.Kidney Int1985; 28: 338.
18.
HombrouckxR.O., De VosJ.Y., GlibertB.H.. Creatine phosphokinase increase during dialysis by red cell fragmentation.Nephrol Dial Transplant1992; 7: 965–6.
